MMS officers frequently offer testimony and/or legal perspectives to state and federal officials on issues relevant to Massachusetts physicians and their patients.
-
MMS Testimony Concerning Proposed Amendments to 105 CMR 700.000
July 30, 2014
The Massachusetts Medical Society (“MMS”) appreciates the opportunity to comment on the latest adaptations to the regulations of the Prescription Monitoring Program (“PMP”). The MMS strongly supports effective efforts to limit prescription drug abuse and diversion and to improve collective efforts...
-
MMS Testimony Regarding the Division's Request for Comment - Risk Bearing Provider Organizations Bulletin and Regulation
June 23, 2014
The MMS is concerned that the reporting and registration burdens associated with the requirements of Chapter 224 will drive further consolidation and employment trends in the Massachusetts health care marketplace or result in physicians ceasing to practice.
-
Testimony Concerning Emergency Regulations 247 CMR 9.04(8)
June 13, 2014
MMS testimony regarding proposed emergency regulations regarding the dispensing extended release hydrocodone.
-
Testimony On House 4121 An Act Relative to the Reduction of Gun Violence
June 3, 2014
As the Committee on Public Safety and Homeland Security considers the legislation before you today, relative to firearms and gun control, the MMS would like to bring the following facts and Society policies to the members’ attention.
-
MMS Statement on Drug Abuse and Opioid Addiction
May 6, 2014
MMS comments on several effective approaches to curbing drug and opioid abuse in Massachusetts.
-
Testimony In Opposition to House 1632 An Act To Regulate And Tax The Cannabis Industry
April 24, 2014
The Massachusetts Medical Society (MMS) wishes to be recorded in opposition to House 1632 because it goes against established policies of the MMS in opposing recreational use of marijuana. Just last week a study published in the Journal of Neuroscience connected marijuana use to brain...
-
MMS Testimony in Support of H.1227 An Act Relative to the Valuation of Professional Practices in Divorce Proceedings
April 8, 2014
The Massachusetts Medical Society (MMS) wishes to be recorded in support for H.1227, “An Act Relative to the Valuation of Professional Practices in Divorce Proceedings.” The MMS is grateful to Rep. Michael Brady for filing this legislation.
-
Comments on the Health Policy Council's Patient Centered Medical Home Certification Criteria
March 25, 2014
The Massachusetts Medical Society (MMS) agrees with the definition of a patient-centered medical home (PCMH) as care that is accessible, comprehensive, continuous, coordinated, family-centered, compassionate, culturally-competent, and in which the primary care physician shares responsibility for...
-
MMS Testimony In Opposition To H.939 An Act Relative To Consumer Choice Of Nurse Midwife Services
March 5, 2014
The Massachusetts Medical Society (MMS) wishes to be recorded in opposition to H.939, “An Act Relative to Consumer Choice of Nurse Midwife Services.” If passed, this bill would significantly expand the scope of practice and practice settings of certified nurse midwives (CNM’s).
-
MMS Testimony Concerning Senate Bill 467 An Act Relative To Telemedicine
March 5, 2014
The Massachusetts Medical Society wishes to offer the following points for the Committee’s consideration in reviewing S.467. The bill defines telemedicine as: “the use of audio, video or other electronic media for the purpose of diagnosis, consultation, or treatment as it pertains to the delivery...
-
Testimony on Proposed Draft Regulation 958 CMR 6.00, Registration of Provider Organizations
February 12, 2014
In regulatory testimony, MMS cautions the Health Policy Commission about the potential administrative burdens of a state provider registration system.
-
Testimony In Support of Senate 1038 An Act To Improve Quality, Encourage Peer Review and Reduce Costs in Health Care
December 17, 2013
Massachusetts is engaged in serious efforts to improve access to affordable and high quality health care. Initiatives include recommendations on new delivery models such as accountable care organizations and reductions in costs associated with defensive medicine.
